What is Ohio State University Medical Center Clinical Trial (Pill Form)?
CATEGORY:
Investigators are recruiting 400 people with relapsing-remitting MS for a study evaluating three doses of ACT-128800, an oral compound that affects immune function, versus placebo. The study sponsor is Actelion Pharmaceuticals, Ltd
Save up to 80% off your prescriptions!
We currently don't have enough shared data that is made public for this treatment.
Let's build this page together! When you share what it's like to have Ohio State University Medical Center Clinical Trial (Pill Form) through your profile, those stories and data appear here too.
Learn more about our community’s experience with Ohio State University Medical Center Clinical Trial (Pill Form)
What are people saying about Ohio State University Medical Center Clinical Trial (Pill Form)?
2
2
members have reported taking Ohio State University Medical Center Clinical Trial (Pill Form)
Join the conversation and connect with people who have taken Ohio State University Medical Center Clinical Trial (Pill Form)
Last updated: